Journal of Immunology Research / 2018 / Article / Tab 5

Research Article

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients

Table 5

Other treatments received after ACT.

PatientOther treatments received after TILs
FirstResponseSecondResponseThirdResponse

1NANA
2Lilly study (tasisulam versus paclitaxel)NA (study suspended)FoteNAMEKiSD
3FotePD
4None
5IpilimumabPRIpilimumabSDSurg (single skin met)CR
6Fote DCBCR
7IpilimumabPR at 2 mo then PD
8None
9Carbo DCBPD
10Carbo DCBSDIpilimumabSD

Carbo: carboplatin; CR: complete response; DCB: dacarbazine; Fote: fotemustine; MEKi: MEK inhibitor; met: metastasis; mo: months; NA: data not available; PD: progressive disease; PR: partial response; SD: stable disease; Surg: surgery.